healthliberal

The Hidden Heroes of Science: A Fight Against Time

USAThursday, December 4, 2025
Advertisement

In the U.S., science often faces criticism, but the real issue might be how drug companies communicate. A few years back, a person in the pharmaceutical industry learned this the hard way.

A Sudden Turn

They had a job creating messages to support science against policies that could harm it. Then, their life took a sudden turn.

One day, they felt pain in their back and thought it was just a muscle pull. But it turned out to be something much worse: multiple myeloma, a rare and serious cancer.

A Fight for Survival

Thanks to their connections, they found a doctor who knew how to treat it. The treatment included chemotherapy, immunotherapy, and even a bone marrow transplant.

Fifteen years ago, this cancer was a death sentence. Today, they are alive because of science and the researchers who spent decades finding a cure.

The Cost of Progress

The development of these treatments took over 30 years and cost billions. Most of that money came from drug companies, not taxpayers.

Now, the person is in remission and on a clinical trial for a new treatment that might keep the cancer away for years.

The Real Heroes

But here's the thing: no one wants to buy drugs. Patients only appreciate them because they need them. The real heroes are the healthcare workers and researchers who make survival possible.

Drug companies should focus on promoting science, not just their products.

The Silent Majority

There are over 2 million people involved in the drug discovery process. But drug companies rarely talk about them. If they had spent more time and money promoting these researchers and their hard work, maybe the public would be more supportive of science.

Right now, bad policies are hurting research and even lifesaving vaccines.

A Call to Action

It's time for scientific researchers to speak up. Groups like AARP spend millions demonizing the pharmaceutical industry. The scientific community needs to fight back.

Drugmakers need to change their approach and celebrate science.

Actions